Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1970 Sep;32(5):671–674. doi: 10.1136/hrt.32.5.671

The pathogenesis of endomyocardial fibrosis: the question of 5-hydroxytryptamine

G O Ojo 1
PMCID: PMC487390  PMID: 5470049

Abstract

Thirty Nigerians with established endomyocardial fibrosis were studied. Basal serum 5-hydroxytryptamine levels were estimated on three different occasions at one-monthly intervals. Twentyfour hours before each estimation, dietary staples containing 5-hydroxytryptamine were excluded from the diet. Subsequently the patients were fed on a plantain diet and serum levels of 5-hydroxytryptamine were estimated at one- and three-hour intervals after plantain ingestion. 5-hydroxytryptamine was assayed on the fundal strip of rat's stomach. These values were compared with those obtained in an earlier study on healthy Nigerians. It was observed that, as in healthy Nigerians, no significant increase in serum 5-hydroxytryptamine levels occurred in these patients after plantain ingestion. The difference between endomyocardial fibrosis and carcinoid heart disease is underlined and it is emphasized that no correlation exists between the incidence of endomyocardial fibrosis and the high content of 5-hydroxytryptamine in the local dietary staples.

Full text

PDF
671

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARNOTT W. M. A problem in tropical cardiology. Br Med J. 1959 Dec 12;2(5162):1273–1277. doi: 10.1136/bmj.2.5162.1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Antia A. U., Talbert J. L., Paplanus S. H. Etiology of endomyocardial fibrosis: an experimental evaluation of plantain ingestion and chronic lymphatic obstruction. Johns Hopkins Med J. 1968 Feb;122(2):87–93. [PubMed] [Google Scholar]
  3. BALL J. D. Endomyocardial fibrosis. Proc R Soc Med. 1957 Jan;50(1):43–46. doi: 10.1177/003591575705000111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. ETTLINGER G. Visual discrimination following successive unilateral temporal excisions in monkeys. J Physiol. 1958 Feb 17;140(2):38–9P. [PubMed] [Google Scholar]
  5. FISCHER S., LINDENEG O. Cardiac changes in argentaffinomatosis. Acta Pathol Microbiol Scand. 1958;44(2):128–137. doi: 10.1111/j.1699-0463.1958.tb01062.x. [DOI] [PubMed] [Google Scholar]
  6. Lin R. C., Yeoh T. S. An improvement on Vane's stomach strip preparation for the assay of 5-hydroxytryptamine. J Pharm Pharmacol. 1965 Aug;17(8):524–525. doi: 10.1111/j.2042-7158.1965.tb07718.x. [DOI] [PubMed] [Google Scholar]
  7. ROBERTS W. C., SJOERDSMA A. THE CARDIAC DISEASE ASSOCIATED WITH THE CARCINOID SYNDROME (CARCINOID HEART DISEASE). Am J Med. 1964 Jan;36:5–34. doi: 10.1016/0002-9343(64)90145-7. [DOI] [PubMed] [Google Scholar]
  8. SJOERDSMA A., WEISSBACH H., UDENFRIEND S. A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Am J Med. 1956 Apr;20(4):520–532. doi: 10.1016/0002-9343(56)90136-x. [DOI] [PubMed] [Google Scholar]
  9. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES